M. Raunkjær, K. F. Haselmann, and J. Wengel
494
ammonia and MeOH [0.5% sat. methanolic ammonia, 0–3% MeOH/(v/v/v)] in
DCM as eluent to give nucleoside 18R (580 mg, 84%) as a white foam. 1H NMR
dH (DMSO-d6) 11.4 (s, 1 H, NH) 7.87 (d, J ¼ 7.4 Hz, 2H, ArFmoc), 7.56
(d, J ¼ 7.2 Hz, 2H, ArFmoc), 7.43–7.20 (m, 14H, ArDMT, ArFmoc and H-6), 6.88
(d, J ¼ 7.8 Hz, 4H, ArDMT), 5.91 (d, J ¼ 4.5 Hz, 1H, H-10), 5.75 and 5.70
(s, 2H, NH and 30-OH), 4.35 (d, J ¼ 6.6 Hz, 2H, CHCHF2moc), 4.23
(t, J ¼ 6.4 Hz, 1H, CHCH2Fmoc), 4.15 (m, 2H, H-20 and H-200), 4.00 (m, 1H,
H-40), 3.74 (s, 6H, 2 ꢁ OCH3), 3.32 (m, 6H, Ha-300, Hb-300, Ha-50, Hb-5 and
CHp2ip), 2.46 (m, 2H, CH2pip), 2.24–2.07 (m, 5H, Ha-100 and 2 ꢁ CH2pip), 1.81
(s, 3H, CH3), 1.61 (m, 1H. Hb-100); 13C NMR dC (DMSO-d6) 163.7, 154.2 and
150.0 (CO), 158.1, 154.2, 144.8, 143.8, 140.7, 137.5, 135.5, 135.4, 129.7,
127.8, 127.7, 127.6, 127.1, 126.7, 125.0, 120.0, 113.2 and 107.4 (C5, C6 and
Ar), 87.6, 86.6, 85.7, 82.3, 81.0, 79.8, 66.4, 62.2, 60.7, 55.0, 54.9, 52.7, 46.8,
43.3 and 12.1; HRMS [M þ Na]þ m/z 929.3755 (calcd. 929.3732).
(1S,3S,5R,6R,8R)-6-((4,40-Dimethoxytrityl)oxymethyl)-5-hydroxy-3-(N-
[9-fluorenylmethoxycarbonyl]piperazino)methyl-8-(thymin-1-yl)-2,7-
dioxabicyclo[3.3.0]octane (18S). The procedure for preparation of
compound 18R was used. Compound 16S (282 mg, 0.47 mmol) was reacted
with DMTCl (473 mg, 1.40 mmol) in a mixture of anhydrous DCM (10 mL)
and CH3CN (10 mL) in the presence of DIPEA (325 mL, 0.742 mmol). Nucleo-
1
side 18S (373 mg, 88%) was obtained as a white foam. H NMR dH (DMSO-
d6) 11.5 (s, 1 H, NH) 7.87 (d, J ¼ 7.8 Hz, 2H, ArFmoc), 7.60 (d, J ¼ 7.1 Hz, 2H,
ArFmoc), 7.44–7.21 (m, 14H, ArDMT, ArFmoc and H-6), 6.89 (d, J ¼ 9.0 Hz, 4H,
ArDMT), 5.87 (d, J ¼ 3.6 Hz, 1H, H-10), 5.80 (s, 2H, NH and 30-OH), 4.36
(d, J ¼ 6.3 Hz, 2H, CHCH2Fmoc), 4.25 (t, J ¼ 6.1 Hz, 1H, CHCHF2moc), 4.18
(d, 1H, H-20), 4.06 (m, 1H, H-40), 3.92 (m, 1H, H-200), 3.74 (s, 6H, 2 ꢁ OCH3),
3.40–3.32 (m, 6H, Ha-300, Hb-300, Ha-50, Hb-5 and CH2pip), 2.48 (m, 2H, CHp2ip),
2.27–2.09 (m, 4H, 2 ꢁ CHp2ip), 1.96 (dd, J ¼ 5.4 and 12.8, 1H, Ha-100), 1.80
(s, 3H, CH3), 1.60 (dd, 1H, J ¼ 9.4 and 12.4, 1H Hb-100); 13C NMR dC (DMSO-
d6) 163.7, 158.1, 158.0, 149.9, 144.7, 142.5, 139.4, 137.4, 136.5, 135.4, 135.3,
129.8, 128.9, 127.8, 127.7, 127.2, 126.7, 121.4, 120.0, 113.2 and 109.7 (CO,
C5, C6 and Ar), 86.5, 86.4, 86.1, 85.8, 84.2, 79.1, 61.8, 55.0, 54.9, 54.5, 45.4,
43.3 and 12.1; HRMS [M þ Na]þ m/z 929.3755 (calcd. 929.3732).
(1S,3R,5R,6R,8R)-6-((4,40-Dimethoxytrityl)oxymethyl)-5-hydroxy-3-(N-
[pyren-1-ylbutanoyl]piperazino)methyl-8-(thymin-1-yl)-2,7-dioxabicyclo
[3.3.0]octane (19R). The procedure for preparation of compound 18R was used.
Compound 17R (120 mg, 0.18 mmol) was reacted with DMTCl (186 mg,
0.55 mmol) in a mixture of anhydrous DCM (3 mL) and CH3CN (3 mL) in the
presence of DIPEA (160mL, 0.92 mmol). Nucleoside 19R (135 mg, 77%) was
1
obtained as a white foam. H NMR dH (CDCl3) 8.30 (d, J ¼ 9.2 Hz, 1H, Arpyr),
8.16–7.96 (m, 7H, Arpyr), 7.89 (d, J ¼ 7.8 Hz, 1H, Arpyr), 7.55–7.21 (m, 9H, H-6